This study is looking at a new way to diagnose biliary atresia, a rare liver disease in infants where bile ducts are blocked. We are testing a special dye called Indocyanine Green (ICG). This dye is non-radioactive and glows under a special camera. It's taken up by the liver and then leaves the body in stool. We want to see if we can detect this dye in your baby's stool 24 hours after an injection to help diagnose biliary atresia. We are looking for infants up to 3 months old who have cholestasis (high direct bilirubin) and are already having a diagnostic HIDA scan. Your baby cannot participate if they have kidney disease, bloody stools, a history of bowel surgery, or an allergy to ICG, iodine, or shellfish. The study aims to enroll 20 participants, but its current recruitment status is unclear.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 20 participants.

What's involved

Participants will receive a one-time injection of Indocyanine Green (ICG). Stool will be collected and tested 24 hours after the injection.

Compensation

Not stated in the trial record.

Follow-up

The primary measurement is taken 24 hours after the injection.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.